Proportion of Patients With a Sustained Virological Response (Serum HBV DNA <20 IU/mL) at Week 48
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Tenofovir Monotherapy in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Entecavir Plus Tenofovir (NCT03236610) | Uijeongbu St. Mary Hospital | 2016-01-01 |
| Tenofovir Monotherapy in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Lamivudine Plus Adefovir (NCT03236584) | Uijeongbu St. Mary Hospital | 2015-09-01 |
Track Proportion of Patients With a Sustained Virological Response (Serum HBV DNA <20 IU/mL) at Week 48 automatically
Every clearance here is in the API, with alerts when new ones post.